首页 | 本学科首页   官方微博 | 高级检索  
检索        

重组组织型纤溶酶原激活剂治疗急性心肌梗塞42例临床分析
引用本文:陈国伟,潘永康,李兆文,杨柯,李婺芳,袁贤奇,龙凤军,郭有方.重组组织型纤溶酶原激活剂治疗急性心肌梗塞42例临床分析[J].中国循环杂志,1994(1).
作者姓名:陈国伟  潘永康  李兆文  杨柯  李婺芳  袁贤奇  龙凤军  郭有方
作者单位:澳门镜湖医院监护病室,广州中山医科大学第一附属医院心内科,北京中国医学科学院阜外医院内科
摘    要:本文报道应用重组组织型纤溶酶原激活剂(rt-PA)治疗42例急性心肌梗塞,对其临床效果进行分析,证实rt-PA有缩小梗塞范围,改善心功能,提高患者生活质量和降低病死率的作用。在用药过程中。本组病例未见到严重出血及其他严重副作用。作者对rt-PA的给药时机、应用指征及禁忌证作了探讨。

关 键 词:急性心肌梗塞,重组组织型纤溶酶原激活剂,溶血栓疗法

USE OF RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR IN THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION: A CLINICAL ANALYSIS OF 42 PATIENTS.
Chen Guo-Wei,Pan Yong-Kang, Li Zhao-Wen,et al..USE OF RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR IN THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION: A CLINICAL ANALYSIS OF 42 PATIENTS.[J].Chinese Circulation Journal,1994(1).
Authors:Chen Guo-Wei  Pan Yong-Kang  Li Zhao-Wen  
Institution:Intensive Care Unit; Kiang Wu Hospital; Macau.
Abstract:The use of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of 42 Patients of acute myocardial infarction was reported. The clinical effects of rt-PA were analysed. The use of rt-PA could: 1. decrease the size of myocardial infarction; 2.improve left ventricular function; 3. improve live quality, and 4. reduce mortality. No serious hemorrhage or other serious side effects were found during the treatment. Appropriate time of administration, indication and contraindication of rt-PA were discussed.
Keywords:Acute myocardial infarction (AMI)  Recombinant tissue-type plasminogen activator (rt-PA)  Thrombolytic therapy  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号